Provider
QP75-20 Commercial Pharmacy Benefit Exclusion for Aralast®NP, Eylea®, Glassia®, Lucentis®, Prolastin®-C, and UpliznaTM
Program effective Date: Aug 12, 2020
Documents & Forms Results
Displaying 2451 - 2460 of 3279 results
Provider
QP70-20 In-Home Test Kits 2020 Program Details for Medicare Advantage and SecureBlue Members
Program effective Date: Aug 12, 2020
Provider
P61-20 Site of Service for Selected Outpatient Procedures: XI-03 Medical Policy Update
Program effective Date: Aug 03, 2020
Provider
P28R1-20 Update: Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Aug 03, 2020
Provider
P57-20 Site of Service Program Updates for Selected Specialty Medical Drugs for Commercial Subscribers: Medical Policy XI-06
Program effective Date: Aug 03, 2020
Provider
P63-20 Prior Authorization Updates for Skilled Nursing Facility Admissions
Program effective Date: Aug 03, 2020
Provider
P55-20 New Prior Authorization Timeframes Required by Legislation
Program effective Date: Aug 03, 2020
Provider
P58-20 Hereditary Angioedema (HAE) Drug Prior Authorization Management Changes for generic Icatibant, Firazyr, Haegarda, and Takhzyro — Effective October 5, 2020
Program effective Date: Aug 03, 2020
Provider
P56-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective October 5, 2020
Program effective Date: Aug 03, 2020